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NEWS AND PERSPECTIVES
Infection with Neisseria gonorrhoeae, a Gram-
negative diplococcus, can cause cervititis, urethri-
tis, pelvic inflammatory disease, and result in
long-term sequelae such as infertility, ectopic
pregnancy, and chronic pelvic pain. Gonorrhea in-
fection may increase susceptibility to and trans-
mission of HIV infection.1,2 Endocervix and
urethra are the most common infection sites.
Pharynx and rectal infections are also increasingly
being reported.3 Recently, in many countries, in-
creases in the incidence of gonorrhea have been
greatest among men who have sex with men4 and
in young people. Globally, N. gonorrhoeae causes
an estimated 62 million cases of gonococcal dis-
ease annually.5 In Taiwan, 1629 new cases were
reported in 2008, with an incidence of 7.1 per
100,000 population.6 However, underestimation
is quite probable because of underdiagnosis and
underreporting.7
Over the last decades, N. gonorrhoeae strains
have developed a high level of resistance against
several antimicrobial agents such as penicillin and
tetracycline.8 In Taiwan, an increase in the resist-
ance rate of N. gonorrhoeae to penicillin from 17%
in 1967 to 88.8% in 1990 was reported.9 The
emergence and spread of quinolone-resistant gon-
ococci in Asia and, subsequently, worldwide in
recent years has further limited therapeutic cho-
ices.10–12 Before 1990, there were no gonococcal
strains with resistance to quinolones or third-
generation cephalosporins reported in Taiwan.9
However, high ciprofloxacin resistance rates of
N. gonorrhoeae of 95.2% and 76.7% have been
reported in northern Taiwan in 2005 and 2007, 
respectively.13,14 Discontinuation of fluoroquin-
olone treatment should be recommended at least
in specific subgroups and subregions.15 Recently,
third-generation cephalosporins were proposed as
alternative antibiotics for the treatment of gonor-
rhea. However, in Taiwan, the resistance rate to the
oral cephalosporin cefixime increased from 9%
in 2003 to 16.4% in 2007, and resistance to cef-
podoxime was 21.2% in 2007.13,14 Susceptibility
of N. gonorrhoeae to injectable ceftriaxone remains
100% in Taiwan and worldwide.
Molecular epidemiology studies, such as 
N. gonorrhoeae multi-antigen sequence typing
(NG-MAST) analysis, are helpful in identifying
groups at high risk and domestic or international
transmission routes of specific strains.16 Integration
of NG-MAST and resistant profiles of N. gonor-
rhoeae strains identified that the isolates belong-
ing to the major sequence types (ST) clusters
may be from patients belonging to specific groups
at high risk and exhibit distinct resistant profiles.
Increasing frequency of gonococci with reduced
susceptibility to quinolones and third-generation
cephalosporins, especially in some groups at high
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risk such as men who have sex with men, has
been noted.14,17 Continuous surveillance is essen-
tial to monitor the transmission of specific clones
across national boundaries and among different
sexual networks. Efforts should be made to block
the transmission of gonorrhea via groups at high
risk and to prevent the emergence of resistant
strains and contain their spread.
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